Roman Nettle (Urtica pilulifera)

Roman Nettle (Urtica pilulifera) is a Mediterranean flowering plant whose phenolic compounds, flavonoids, and sterols drive its therapeutic activity through antioxidant, anti-inflammatory, and aromatase-inhibiting mechanisms. Its bioactive constituents modulate oxidative stress pathways and sex hormone metabolism, positioning it as a candidate in traditional and emerging phytomedicine.

Origin & History

Roman nettle (Urtica pilulifera) is an annual herbaceous plant from the family Urticaceae, native to the Mediterranean region. It is harvested from wild populations for traditional medicinal and nutritional purposes, with active compounds extracted using aqueous or methanolic solvents.

Historical & Cultural Context

Roman nettle has been used in traditional European medicine as a tonic and blood purifier. It was historically employed for its antiasthmatic, astringent, depurative, diuretic, and hypoglycemic properties, often prepared as a tea from the leaves.

Health Benefits

• Antioxidant properties demonstrated in vitro with 82.76% free radical scavenging inhibition [2]. • Antibacterial effects observed at 10 mg/mL concentrations in laboratory settings [2]. • Antihemolytic activity shown with IC₅₀ values of 327 μg/mL in methanolic extracts [2]. • Inhibition of aromatase, an enzyme involved in estrogen biosynthesis, observed in methanolic root extracts [1]. • Potential diuretic effects noted in traditional use, but lacking clinical validation [3].

How It Works

Roman Nettle exerts antioxidant effects primarily through its phenolic and flavonoid constituents, which donate hydrogen atoms to neutralize free radicals, achieving 82.76% DPPH scavenging inhibition in vitro. Its antihemolytic activity, with an IC₅₀ of 327 μg/mL in methanolic extracts, is attributed to membrane-stabilizing sterols and polyphenols that reduce oxidative damage to erythrocyte membranes. Aromatase inhibition by plant sterols and lignans reduces peripheral conversion of androgens to estrogens, a pathway relevant to hormone-sensitive conditions.

Scientific Research

The research dossier does not provide specific human clinical trials or meta-analyses for Roman nettle. The evidence is primarily based on laboratory and cell-based models, with no PubMed PMIDs available for human studies.

Clinical Summary

Current evidence for Roman Nettle derives predominantly from in vitro laboratory studies rather than randomized controlled human trials, limiting direct clinical translation. Antibacterial activity has been demonstrated at 10 mg/mL concentrations against select pathogens in agar diffusion assays, though minimum inhibitory concentrations vary by bacterial strain and extract preparation. Antioxidant and antihemolytic data are based on cell-free and erythrocyte models, which do not reliably predict bioavailability or in vivo efficacy. The evidence base is preliminary and substantially weaker than that for better-studied Urtica species such as Urtica dioica; human clinical trials are absent.

Nutritional Profile

Roman Nettle (Urtica pilulifera) shares compositional similarities with common nettle (U. dioica) but with species-specific variations. Documented bioactive compounds include polyphenolic antioxidants responsible for the 82.76% free radical scavenging activity observed in vitro, with methanolic extracts yielding measurable flavonoids and phenolic acids. Chlorophyll content contributes to the green pigmentation and is present in leaf fractions. Mineral content typical of Urtica species includes iron (estimated 1.6–4.0 mg/100g fresh weight), calcium (estimated 400–500 mg/100g dry weight), magnesium, potassium, and silica, though species-specific quantification for U. pilulifera remains limited in published literature. Protein content in Urtica genus leaves generally ranges from 2–5 g/100g fresh weight, with essential amino acids present. Dietary fiber is a notable component of the leaf matrix, aiding bioavailability of minerals through gut transit effects. Lectin compounds (Urtica Agglutinin homologs) are likely present in root fractions based on genus-level data, consistent with the observed aromatase inhibition in methanolic root extracts. Carotenoids including beta-carotene (provitamin A) and lutein are expected in leaf tissue. Vitamin C and vitamin K are present in Urtica leaves generally; specific concentrations for U. pilulifera are not independently confirmed but are estimated at 30–80 mg/100g and 200–500 μg/100g respectively by analogy. Bioavailability of iron may be moderated by oxalic acid content typical of the genus. The antihemolytic IC₅₀ of 327 μg/mL in methanolic extracts suggests moderate concentration of membrane-protective polyphenols.

Preparation & Dosage

No clinically studied dosage ranges for Roman nettle in human subjects are provided in the research. Traditional use involved leaf tea preparations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Stinging nettle, green tea, turmeric, ginger, rosemary

Safety & Interactions

Roman Nettle has no well-characterized human safety profile due to the absence of formal clinical trials, and most tolerability assumptions are extrapolated from related Urtica species. Its aromatase-inhibiting activity raises a theoretical interaction risk with hormone therapies, including estrogen replacement therapy and aromatase inhibitor drugs such as anastrozole or letrozole, potentially producing additive effects. Individuals taking anticoagulants, antihypertensives, or diuretics should exercise caution, as other Urtica species have demonstrated effects on blood pressure and fluid balance. Pregnancy and breastfeeding should be considered contraindications in the absence of safety data, and consumption beyond culinary amounts is not recommended without medical supervision.